Patents
US 10912744 B2: Therapeutic formulation for reduced drug side effects
- Granted
- 2021-02-09
- Filed
- 2019-09-23 application 16579054
- Type
- Utility · 6 claims
- Elsewhere
- Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗
Abstract
The present invention provides drug therapy formulations for reducing the side effects associated with a therapeutic. In some embodiments, the present invention provides a reduction in sleep- and diet-related side effects associated with a therapeutic.
Source: PVGPATDIS, file of 2026-04-10 (ipg210209.xml).
Assignees
| Assignee | Type | Place | Also on furp.org | Source |
|---|---|---|---|---|
| KEMPHARM, INC. 57 patents | US company or organization | Four Corners, FL | KEMPHARM, INC Form D issuer EXACT high confidence: identical full name and state | PVGPATDIS, file of 2026-04-10 |
Inventors
| Inventor | Place | Patents | Person page | Source |
|---|---|---|---|---|
| Subhash Desai | Wilmette, IL | 3 | PVGPATDIS, file of 2026-04-10 |
CPC categories
| Subclass | Category | First group | Source |
|---|---|---|---|
| A61K | Preparations for medical, dental or toiletry purposes | A61K31/137 | PVGPATDIS, file of 2026-04-10 |
| A61P | Specific therapeutic activity of chemical compounds or medicinal preparations | A61P1/00 | PVGPATDIS, file of 2026-04-10 |
| Y10T | Technical subjects covered by former us classification | Y10T428/2982 | PVGPATDIS, file of 2026-04-10 |
Cooperative Patent Classification, as currently assigned (one row per subclass).
Assignments and security interests
| Recorded | What | From | To | Reel/frame | Source |
|---|---|---|---|---|---|
| 2026-03-13 | Release of security interest Release of security interest | ALTER DOMUS (US) LLC signed 2026-03-12 | ZEVRA THERAPEUTICS, INC. CELEBRATION, FL | 75080/907 | PASDL, file of 2026-10-15 |
| 2024-04-08 | Security interest Security interest Security interest | ZEVRA THERAPEUTICS, INC. signed 2024-04-05 | ALTER DOMUS (US) LLC CHICAGO, IL | 67040/637 | PASDL, file of 2026-10-15 |
| 2024-02-23 | Name change Change of name | KEMPHARM, INC. signed 2023-02-21 | ZEVRA THERAPEUTICS, INC. CELEBRATION, FL | 66664/108 | PASDL, file of 2026-10-15 |
| 2020-10-06 | Correction Corrective assignment to correct the execution date of assignor, genco sciences llc, incorrectly recorded as 09-27-2017 previously recorded at reel: 053863 frame: 0360. assignor(s) hereby confirms the assognment. | GENCO SCIENCES LLC signed 2017-09-29 | KEMPHARM, INC. CELEBRATION, FL | 53985/770 | ECORSEXC, file of 2026-09-25 |
| 2020-09-23 | Assignment Assignment of assignor's interest | GENCO SCIENCES LLC, signed 2017-09-27 | KEMPHARM, INC. CELEBRATION, FL | 53863/360 | ECORSEXC, file of 2026-09-25 |
Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.
USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.